Table 6.
Propensity Score Assessment for Statin Use
Without Propensity Score Stratification | With Propensity Score Stratification | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | Proportion of Statin Users | Proportion of Statin Nonusers | Std. Diff. | Propensity Score Quintile 1 | Propensity Score Quintile 2 | Propensity Score Quintile 3 | Propensity Score Quintile 4 | Propensity Score Quintile 5 | Mean Std. Diff. | ||||||||||
Proportion of Statin Users | Proportion of Statin Nonusers | Std. Diff. | Proportion of Statin Users | Proportion of Statin Nonusers | Std. Diff. | Proportion of Statin Users | Proportion of Statin Nonusers | Std. Diff. | Proportion of Statin Users | Proportion of Statin Nonusers | Std. Diff. | Proportion of Statin Users | Proportion of Statin Nonusers | Std. Diff. | |||||
Aged >54 y | 0.400 | 0.495 | 0.158 | 0.673 | 0.740 | 0.120 | 0.572 | 0.545 | 0.044 | 0.419 | 0.456 | 0.062 | 0.375 | 0.369 | 0.011 | 0.271 | 0.264 | 0.012 | 0.050 |
Men | 0.451 | 0.447 | 0.007 | 0.472 | 0.466 | 0.010 | 0.471 | 0.422 | 0.080 | 0.423 | 0.427 | 0.006 | 0.452 | 0.459 | 0.011 | 0.467 | 0.473 | 0.009 | 0.023 |
White race | 0.795 | 0.707 | 0.170 | 0.559 | 0.531 | 0.045 | 0.685 | 0.686 | 0.002 | 0.734 | 0.747 | 0.024 | 0.820 | 0.804 | 0.033 | 0.926 | 0.919 | 0.021 | 0.025 |
High school education or higher | 0.819 | 0.740 | 0.159 | 0.497 | 0.530 | 0.055 | 0.725 | 0.742 | 0.032 | 0.847 | 0.811 | 0.079 | 0.866 | 0.852 | 0.031 | 0.889 | 0.887 | 0.004 | 0.040 |
CAD | 0.055 | 0.047 | 0.031 | 0.053 | 0.036 | 0.065 | 0.043 | 0.046 | 0.012 | 0.026 | 0.038 | 0.057 | 0.051 | 0.048 | 0.011 | 0.075 | 0.064 | 0.035 | 0.036 |
Hypertension | 0.330 | 0.357 | 0.046 | 0.454 | 0.437 | 0.027 | 0.363 | 0.326 | 0.065 | 0.295 | 0.335 | 0.071 | 0.305 | 0.317 | 0.020 | 0.301 | 0.297 | 0.008 | 0.038 |
Diabetes mellitus | 0.110 | 0.123 | 0.032 | 0.151 | 0.145 | 0.014 | 0.122 | 0.114 | 0.022 | 0.096 | 0.117 | 0.057 | 0.106 | 0.099 | 0.019 | 0.090 | 0.089 | 0.004 | 0.023 |
LDL >160 mg/dL | 0.372 | 0.219 | 0.271 | 0.019 | 0.022 | 0.022 | 0.077 | 0.073 | 0.013 | 0.125 | 0.153 | 0.068 | 0.352 | 0.343 | 0.015 | 0.737 | 0.691 | 0.084 | 0.040 |
Smoking | 0.562 | 0.592 | 0.049 | 0.645 | 0.682 | 0.063 | 0.585 | 0.589 | 0.007 | 0.553 | 0.558 | 0.010 | 0.567 | 0.559 | 0.014 | 0.543 | 0.540 | 0.005 | 0.020 |
Creatinine>mean | 0.364 | 0.352 | 0.019 | 0.365 | 0.363 | 0.005 | 0.362 | 0.345 | 0.028 | 0.368 | 0.333 | 0.058 | 0.354 | 0.365 | 0.019 | 0.365 | 0.358 | 0.010 | 0.024 |
Antiplatelet at visit 1 | 0.094 | 0.080 | 0.041 | 0.071 | 0.064 | 0.023 | 0.101 | 0.079 | 0.060 | 0.064 | 0.079 | 0.046 | 0.073 | 0.081 | 0.025 | 0.135 | 0.120 | 0.037 | 0.038 |
Anticoagulant at visit 1 | 0.004 | 0.005 | 0.017 | 0.006 | 0.013 | 0.058 | 0.004 | 0.003 | 0.010 | 0.001 | 0.001 | 0.002 | 0.001 | 0.001 | 0.000 | 0.005 | 0.003 | 0.026 | 0.019 |
Std. Diff. values among statin users and nonusers for each visit 1 variable represented in the propensity score for taking the medication from visit 2 to 5 without and with propensity quintile stratification, yielding mean Std. Diff. values. CAD indicates coronary artery disease; LDL, low‐density lipoprotein; and Std. Diff., standardized difference.